Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta‐analysis

Comparing the efficacy and safety of low, medium, and high dosages of selexipag for treating pulmonary hypertension: A systematic review and meta‐analysis

Abstract Background The maintenance dosage of selexipag is categorized as low, medium or high. In order to assess the efficacy and safety of different dosages of selexipag for the risk stratification of pulmonary arterial hypertension (PAH), we performed a systematic review and meta‐analysis. Method...

Full description

Bibliographic Details
Main Authors: Shang Wang, Yi Yan, Jian Zhang, Ping Yuan, Ci‐Jun Luo, Hong‐Ling Qiu, Hui‐Ting Li, Jian Xu, Lan Wang, Tian‐Lan Li, Rong Jiang
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Animal Models and Experimental Medicine
Subjects:
individualized treatments
meta‐analysis
prostacyclin receptor agonist
risk stratification
systematic review
Online Access:https://doi.org/10.1002/ame2.12347

Internet

https://doi.org/10.1002/ame2.12347

Similar Items